---
title: "Vabysmo (faricimab-svoa), all indications: Indication questions"
description: "Indication questions on Vabysmo (faricimab-svoa) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is the generic name of Vabysmo? When was Vabysmo first approved by the FDA? Who makes Vabysmo? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/vabysmo/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Vabysmo (faricimab-svoa), all indications: Indication questions

Manufacturer: Genentech, Inc.  
Prescribing information: [Vabysmo](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf)  
Indication pages: [Neovascular age-related macular degeneration](https://www.evicenter.com/medical-information/vabysmo--neovascular-age-related-macular-degeneration)

## Drug names

<a id="vabysmo-generic-name"></a>

### What is the generic name of Vabysmo?

> “VABYSMO<sup>®</sup> (faricimab-svoa) injection, for intravitreal use”

Source: [VABYSMO: Prescribing information, page 1, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=1)

> “Faricimab-svoa is a humanized bispecific immunoglobulin G1 (IgG1) antibody that binds both 
> vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2).”

Source: [VABYSMO: Prescribing information, page 13, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=13)

<a id="vabysmo-manufacturer"></a>

### Who makes Vabysmo?

> “Manufactured by: 
> Genentech, Inc. 
> A Member of the Roche Group”

Source: [VABYSMO: Prescribing information, page 24, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=24)

## Indication

<a id="vabysmo-fda-approval"></a>

### When was Vabysmo first approved by the FDA?

> “Initial U.S. Approval:  2022”

Source: [VABYSMO: Prescribing information, page 1, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=1)

## Related pages
- [Medical information: Vabysmo (faricimab-svoa): All indications](https://www.evicenter.com/medical-information/vabysmo)
- [Pharmacology](https://www.evicenter.com/medical-information/vabysmo/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/vabysmo/safety)
- [Specific populations](https://www.evicenter.com/medical-information/vabysmo/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/vabysmo/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/vabysmo/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/vabysmo/access-and-coverage)
